title: Secreted protein acidic, rich in cysteine induces pulp cell migration via alphavbeta3 integrin and extracellular signal-regulated kinase.
abstract: OBJECTIVE
  The aim of this study was to investigate the influence of secreted protein acidic, rich in cysteine (SPARC) on the migration of human dental pulp (HDP) cells.
  
  
  METHODS
  Secreted protein acidic, rich in cysteine was applied in the lower chamber of the chemotaxis apparatus and migration was determined by counting the cells that migrated through the membrane. To determine the signaling pathway involved, cells were incubated with inhibitors for 30 min prior to the migration assay.
  
  
  RESULTS
  The results indicated that SPARC induced HDP cell migration in a dose-dependent manner via extracellular signal-regulated kinase (ERK). The migration could be inhibited both by the anti-alphavbeta3 integrin antibody and by suramin, a non-selective growth factor receptor and G-protein coupled receptor antagonists. The anti-alphavbeta3 integrin antibody could also inhibit ERK activation, suggesting the possible role of alphavbeta3 integrin on the regulation of ERK and cell migration. Interestingly, both suramin and SB225002, another G-protein coupled receptor antagonist, suppressed ERK activation.
  
  
  CONCLUSIONS
  Secreted protein acidic, rich in cysteine could act as a chemotactic factor and facilitate migration, possibly through the G-protein coupled receptor, alphavbeta3 integrin and ERK. The data support that SPARC could play a crucial role in dental pulp tissue repair by inducing dental pulp cell migration.
authors.affiliation: Department of Anatomy, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand. prasit215@gmail.com
authors.forename: P
authors.initials: P
authors.lastname: Pavasant
authors.forename: T
authors.initials: T
authors.lastname: Yongchaitrakul
mesh_terms: D002478:Cells, Cultured; D002633:Chemotaxis / Q000187:drug effects / Q000502:physiology*; D003782:Dental Pulp / Q000166:cytology / Q000502:physiology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D048049:Extracellular Signal-Regulated MAP Kinases / Q000032:analysis / Q000037:antagonists & inhibitors / Q000502:physiology*; D006801:Humans; D039302:Integrin alphaVbeta3 / Q000502:physiology*; D020935:MAP Kinase Signaling System; D015676:Osteonectin / Q000502:physiology*; D010671:Phenylurea Compounds / Q000494:pharmacology; D043562:Receptors, G-Protein-Coupled / Q000037:antagonists & inhibitors / Q000502:physiology; D013498:Suramin / Q000494:pharmacology
chemical_list: D004791:Enzyme Inhibitors; D039302:Integrin alphaVbeta3; D015676:Osteonectin; D010671:Phenylurea Compounds; D043562:Receptors, G-Protein-Coupled; C112019:SB 225002; D013498:Suramin; D048049:Extracellular Signal-Regulated MAP Kinases